MuLBSTA Score for Viral Pneumonia Mortality

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
mulbsta score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–5
  • Moderate Risk6–11
  • High Risk12–12
Direct Clinical Answer

The MuLBSTA Score for Viral Pneumonia Mortality calculator is designed for bedside predicting 90-day mortality risk in patients with viral pneumonia using clinical and laboratory parameters to guide treatment decisions and resource allocation in clinical practice. The resulting score directly guides clinician decision-making regarding determining.

Clinical Guidelines & Evidence

Predicts 90-day mortality risk in patients with viral pneumonia using clinical and laboratory parameters to guide treatment decisions and resource allocation.

Clinical Indication

The MuLBSTA Score for Viral Pneumonia Mortality is indicated for bedside clinical practice to support Predicts 90-day mortality risk in patients with viral pneumonia using clinical and laboratory parameters to guide treatment decisions and resource allocation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.

Limitations & Contraindications

Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.

Clinical Pearls & Action Plan

Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Helps guide treatment intensity and resource allocation.

Formula & Variables:

MuLBSTA Score = Multilobar infiltrates (5 points) + Lymphopenia (4 points) + Bacterial coinfection (4 points) + Smoking history (3 points) + Hypertension (2 points) + Age ≥60 years (2 points). Maximum score: 20 points, but practical maximum observed is 12 points.

Input Parameters

NameTypeRequiredDescription
multilobar_infiltratesstringYesPresence of multilobar infiltrates on chest imaging
lymphopeniastringYesLymphocyte count ≤0.8 × 10⁹/L
bacterial_coinfectionstringYesPresence of bacterial coinfection
smoking_historystringYesCurrent or former smoking history
hypertensionstringYesHistory of hypertension
age_60_or_olderstringYesAge 60 years or older

Score Interpretation & Guidance

RangeStageDescription
0–5Low RiskLow risk of 90-day mortality
6–11Moderate RiskModerate risk of 90-day mortality
12–12High RiskHigh risk of 90-day mortality

Evidence-Based References (EBM)

  • Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, et al. Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score. Front Microbiol. 2019;10:2752. doi: 10.3389/fmicb.2019.02752.DOI: 10.3389/fmicb.2019.02752
  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7.DOI: 10.1016/S0140-6736(20)30211-7
  • Fan G, Tu C, Zhou F, Liu Z, Wang Y, Song B, et al. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020;56(3):2002113. doi: 10.1183/13993003.02113-2020.DOI: 10.1183/13993003.02113-2020

Related calculators